SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-23-021223
Filing Date
2023-04-28
Accepted
2023-04-28 08:03:00
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20006675x2_defa14a.htm DEFA14A 9321
2 ny20006675x2_nc01.jpg GRAPHIC 1041388
3 ny20006675x2_nc02.jpg GRAPHIC 823059
  Complete submission text file 0001140361-23-021223.txt   2574606
Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39539 | Film No.: 23860282
SIC: 2834 Pharmaceutical Preparations